tiprankstipranks
Revance Therapeutics (RVNC)
NASDAQ:RVNC
Holding RVNC?
Track your performance easily

Revance Therapeutics (RVNC) Ownership - Who Owns Revance Therapeutics?

624 Followers

Revance Therapeutics (RVNC) Ownership Overview

1.90%29.45%29.18%11.92%27.55%
29.18% Other Institutional Investors
11.92% ETFs
27.55% Public Companies and
Individual Investors
The ownership structure of Revance Therapeutics (RVNC) stock is a mix of institutional, retail, and individual investors. Approximately 70.55% of the company’s stock is owned by Institutional Investors, 1.90% is owned by Insiders, and 27.55% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 17, 2024
Erica Jordan
Chief Commercial Officer
xxxxxxxxxxxxx
$9090
Mar 19, 2024
xxxxxxxxxxxxx
$67436
Mar 19, 2024
Dwight Moxie
Clo & Gc
xxxxxxxxxxxxx
$58276
Mar 19, 2024
xxxxxxxxxxxxx
$62149

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$1072103

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,384,192Institution7.04%30,792,081
5,373,916Institution5.12%22,409,230
5,343,949Institution5.09%22,284,267
4,523,634Institution4.31%18,863,554
3,263,852Institution3.11%13,610,263
3,153,520Institution3.01%13,150,178
2,158,645Institution2.06%9,001,550
1,443,571Institution1.38%6,019,691
1,428,000Institution1.36%5,954,760
1,151,770Institution1.10%4,802,881

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,384,192Institution7.04%30,792,081
4,523,634Institution4.31%18,863,554
3,263,852Institution3.11%13,610,263
3,153,520Institution3.01%13,150,178
2,158,645Institution2.06%9,001,550
1,443,571Institution1.38%6,019,691
1,428,000Institution1.36%5,954,760
1,151,770Institution1.10%4,802,881
1,136,083Institution1.08%4,737,466
1,072,339Institution1.02%4,471,654

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,094,072Institution2.95%16,058,234
2,956,846Institution2.82%12,330,048
1,335,276Institution1.27%6,930,082
933,892Institution0.89%3,894,330
647,390Institution0.62%2,699,616
477,376Institution0.46%2,477,581
429,462Institution0.41%1,850,981
263,477Institution0.25%1,849,399
330,954Institution0.32%1,717,651
238,720Institution0.23%995,462

FAQ

Who Owns Revance Therapeutics (RVNC)?
According to the latest TipRanks data, approximately 29.18% of the company's stock is held by institutional investors, 1.90% is held by insiders, and 27.55% is held by retail investors.
    What percentage of Revance Therapeutics (RVNC) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 29.18% of Revance Therapeutics (RVNC) stock is held by institutional investors.
      What percentage of Revance Therapeutics (RVNC) stock is held by retail investors?
      According to the latest TipRanks data, approximately 27.55% of Revance Therapeutics (RVNC) stock is held by retail investors.
        Who owns the most shares of Revance Therapeutics (RVNC)?
        SMALLCAP World Fund Inc owns the most shares of Revance Therapeutics (RVNC).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis